Browse by author
Lookup NU author(s): Stephen Bromage,
Dr Roger Searle
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Problem: The status of cytokines in amniotic fluid (AF) from chromosomally abnormal pregnancy is largely undefined. TGFβ plays a key role in fetal growth and differentiation and is responsible for the immunoregulatory activity of AF in normal pregnancy, but its status in Down syndrome (DS) pregnancies is unknown. In addition we investigated the IL-2 status of AF from DS pregnancies. Methodof study: Midtrimester AF from chromosomally normal (n = 25) and abnormal pregnancies with DS (n = 15) were assayed for bioactive and latent TGFβ levels using the mink lung epithelial cell growth inhibition bioassay and for IL-2 activity by the CTLL-2 cell proliferation bioassay and by ELISA. Results: Levels of bioactive TGFβ (mean 4.6 ± 0.6 U/mL) were significantly increased in DS AF compared with the normal samples (mean 2.8 ± 0.3 U/mL, P < 0.003) but latent TGFβ levels did not differ between DS and normal groups. In addition DS AFs showed reduced IL-2 like bioactivity compared with normal samples (P = 0.0006) but IL-2 immunoactivity was undetectable in DS and normal AFs by ELISA. Conclusions: DS AFs display increased TGFβ activity and lacked IL-2 immunoactivity. The reduced ability of DS AFs to stimulate CTLL-2 cell proliferation is unrelated to the IL-2 status of AF. Altered TGFβ levels may prove useful as an additional biochemical index for the detection of DS pregnancies.
Author(s): Searle RF; Bromage SJ; Lang AK; Atkinson I
Publication type: Article
Publication status: Published
Journal: American Journal of Reproductive Immunology
ISSN (print): 8755-8920
ISSN (electronic): 1600-0897
Publisher: Wiley-Blackwell Publishing Ltd.
PubMed id: 11076091
Altmetrics provided by Altmetric